Wells Fargo & Company Boston Scientific Corp Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Boston Scientific Corp stock. As of the latest transaction made, Wells Fargo & Company holds 17,000 shares of BSX stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,000

Previous 3,155,487 99.46%

Holding current value

$1.54 Million

Previous $243 Million 99.41%

% of portfolio

0.0%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.96 - $84.0 $3.44 Million - $3.96 Million	-47,109 Reduced 1.49%	3,108,378 $260 Million
Q2 2024 Aug 13, 2024	SELL	$67.33 - $77.71 $2.57 Million - $2.97 Million	-38,217 Reduced 1.2%	3,155,487 $243 Million
Q1 2024 May 10, 2024	BUY	$57.6 - $68.62 $22.9 Million - $27.2 Million	396,799 Added 14.19%	3,193,704 $219 Million
Q4 2023 Feb 09, 2024	SELL	$48.64 - $57.81 $7.58 Million - $9.01 Million	-155,845 Reduced 5.28%	2,796,905 $162 Million
Q3 2023 Nov 13, 2023	SELL	$50.19 - $54.68 $21.6 Million - $23.6 Million	-430,998 Reduced 12.74%	2,952,750 $156 Million
Q2 2023 Aug 15, 2023	SELL	$49.72 - $54.64 $6.8 Million - $7.47 Million	-136,719 Reduced 3.88%	3,383,748 $183 Million
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $8.72 Million - $9.67 Million	-193,368 Reduced 5.21%	3,520,467 $176 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $1.3 Million - $1.55 Million	-32,856 Reduced 0.88%	3,713,835 $172 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $90,673 - $270,860	-2,470 Reduced 0.07%	3,746,691 $145 Million
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $29.4 Million - $39.4 Million	-835,614 Reduced 18.23%	3,749,161 $140 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $27.4 Million - $30.2 Million	669,036 Added 17.09%	4,584,775 $203 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $150 Million - $177 Million	-3,944,533 Reduced 50.18%	3,915,739 $166 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $14.4 Million - $16 Million	348,398 Added 4.64%	7,860,272 $341 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $17.4 Million - $20 Million	451,146 Added 6.39%	7,511,874 $321 Million
Q1 2021 May 13, 2021	SELL	$35.27 - $39.67 $56 Million - $63 Million	-1,588,179 Reduced 18.36%	7,060,728 $273 Million
Q4 2020 Feb 09, 2021	SELL	$33.15 - $41.97 $82.7 Million - $105 Million	-2,494,701 Reduced 22.39%	8,648,907 $311 Million
Q3 2020 Nov 05, 2020	SELL	$34.44 - $42.23 $7.03 Million - $8.62 Million	-204,107 Reduced 1.8%	11,143,608 $426 Million
Q2 2020 Aug 13, 2020	SELL	$30.19 - $39.11 $36 Million - $46.7 Million	-1,193,032 Reduced 9.51%	11,347,715 $398 Million
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $324 Million - $573 Million	12,540,747 New	12,540,747 $409 Million

Others Institutions Holding BSX

# of Institutions

1,538

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Boston Scientific Corp Transaction History